StockEdge.com
  • Go Premium
    • StockEdge Quarterly Plan
    • StockEdge Annual Plan
    • StockEdge Analyst
    • StockEdge Club
    • Compare Plans
StockEdge Blog
  • Trending Stocks
  • Insights
    • All
    • Business Houses
    • Markets themes
    • Stock Insights
    How Page Industries is creating a “branded” opportunity in a fragmented market

    How Page Industries is creating a “branded” opportunity in a fragmented market

    5 Stocks which are Consistently Paying Dividend

    5 Stocks which are Consistently Paying Dividend

    Elgi Equipments – Enjoying Strong Tailwinds

    Elgi Equipments – Enjoying Strong Tailwinds

    J.B. Chemicals & Pharmaceuticals – One of India’s fastest-growing pharmaceutical companies

    J.B. Chemicals & Pharmaceuticals – One of India’s fastest-growing pharmaceutical companies

    Blue Dart Express – A market leader in Air Express Industry

    Blue Dart Express – A market leader in Air Express Industry

    Hindustan Foods – A market leader in FMCG contract manufacturing

    Hindustan Foods – A market leader in FMCG contract manufacturing

    Sharda Cropchem – Ending the year with a strong performance in Q4FY22

    Sharda Cropchem – Ending the year with a strong performance in Q4FY22

    ABB India – An outstanding overall performance

    ABB India – An outstanding overall performance

    Apcotex Industries Ltd. – Strongly Outperforming

    Apcotex Industries Ltd. – Strongly Outperforming

  • Technical Analysis
    Derivative Analytics

    Derivative Analytics – An Insightful Research Tool

    Put-Call Ratio – A Powerful Derivatives Indicator

    Put-Call Ratio – A Powerful Derivatives Indicator

    Beta & Beta Scans – A Powerful Technical Indicator

    Beta & Beta Scans – A Powerful Technical Indicator

    Technical Analysis using Edge Charts

    Technical Analysis using Edge Charts

    Adaptive Relative Strength & Static Relative Strength Scans

    Adaptive Relative Strength & Static Relative Strength Scans

    SuperTrend Indicator : Sell or Buy Signals

    SuperTrend Indicator : Sell or Buy Signals

    2 year and 5 year Price Breakout Scans

    2 year and 5 year Price Breakout Scans

    What is Narrow Range Scans (NR)

    What is Narrow Range Scans (NR)

    Relative Strength (RS)

    Relative Strength (RS)

  • Fundamental Analysis
    • All
    • Cash Flow Ratios
    • Efficiency ratios
    • Growth Ratios
    • Liquidity Ratios
    • Return Ratios
    • Solvency ratios
    • Valuation Ratios
    Understanding the Importance of creating Fundamental Scans

    Understanding the Importance of creating Fundamental Scans

    Using My Combination Scan to Identify best in an Industry

    Using My Combination Scan to Identify best in an Industry

    Cost Income ratio

    Cost to Income Ratio(%)

    Cost of Liability

    Cost of Liabilities (%)

    Operating Cost to Assets Ratio (%)

    Operating Cost to Assets Ratio (%)

    Promoter pledge

    Promoter Pledge: Know Everything about it

  • StockEdge Tutorials
    StockEdge Version 8.1 – It keeps getting Better & Better

    StockEdge Version 8.1 – It keeps getting Better & Better

    StockEdge Version Update 8.0 – Like never before

    StockEdge Version Update 8.0 – Like never before

    Derivative Analytics

    Derivative Analytics – An Insightful Research Tool

    Market Breadth – A Bird’s Eye View of the Market at 1 place

    Market Breadth – A Bird’s Eye View of the Market at 1 place

    StockEdge Version 7.6 released – Enhancing your investment journey further!

    StockEdge Version 7.6 released – Enhancing your investment journey further!

    Using Investor Portfolios Section to track Big Bulls like Rakesh Jhunjhunwala

    Using Investor Portfolios Section to track Big Bulls like Rakesh Jhunjhunwala

    Beta & Beta Scans – A Powerful Technical Indicator

    Beta & Beta Scans – A Powerful Technical Indicator

    StockEdge Version Update 7.4 – Enhancing your Investment Journey

    StockEdge Version Update 7.4 – Enhancing your Investment Journey

    StockEdge 7.3 Release

    StockEdge 7.3 Release

  • Mutual Fund
    Top 5 Mutual Funds for 2022 where you can start your SIP

    Top 5 Mutual Funds for 2022 where you can start your SIP

    What are Value Funds and its Advantages?

    What are Value Funds and its Advantages?

    A Beginners Guide to Thematic Funds

    A Beginners Guide to Thematic Funds

    Understanding Sector Funds and their Benefits to our Portfolio

    Understanding Sector Funds and their Benefits to our Portfolio

    Are Dividend Yield Funds a good option to invest in?

    Are Dividend Yield Funds a good option to invest in?

    What are Contra Funds and their advantages?

    What are Contra Funds and their advantages?

    Trending Tags

    No Result
    View All Result
    • Trending Stocks
    • Insights
      • All
      • Business Houses
      • Markets themes
      • Stock Insights
      How Page Industries is creating a “branded” opportunity in a fragmented market

      How Page Industries is creating a “branded” opportunity in a fragmented market

      5 Stocks which are Consistently Paying Dividend

      5 Stocks which are Consistently Paying Dividend

      Elgi Equipments – Enjoying Strong Tailwinds

      Elgi Equipments – Enjoying Strong Tailwinds

      J.B. Chemicals & Pharmaceuticals – One of India’s fastest-growing pharmaceutical companies

      J.B. Chemicals & Pharmaceuticals – One of India’s fastest-growing pharmaceutical companies

      Blue Dart Express – A market leader in Air Express Industry

      Blue Dart Express – A market leader in Air Express Industry

      Hindustan Foods – A market leader in FMCG contract manufacturing

      Hindustan Foods – A market leader in FMCG contract manufacturing

      Sharda Cropchem – Ending the year with a strong performance in Q4FY22

      Sharda Cropchem – Ending the year with a strong performance in Q4FY22

      ABB India – An outstanding overall performance

      ABB India – An outstanding overall performance

      Apcotex Industries Ltd. – Strongly Outperforming

      Apcotex Industries Ltd. – Strongly Outperforming

    • Technical Analysis
      Derivative Analytics

      Derivative Analytics – An Insightful Research Tool

      Put-Call Ratio – A Powerful Derivatives Indicator

      Put-Call Ratio – A Powerful Derivatives Indicator

      Beta & Beta Scans – A Powerful Technical Indicator

      Beta & Beta Scans – A Powerful Technical Indicator

      Technical Analysis using Edge Charts

      Technical Analysis using Edge Charts

      Adaptive Relative Strength & Static Relative Strength Scans

      Adaptive Relative Strength & Static Relative Strength Scans

      SuperTrend Indicator : Sell or Buy Signals

      SuperTrend Indicator : Sell or Buy Signals

      2 year and 5 year Price Breakout Scans

      2 year and 5 year Price Breakout Scans

      What is Narrow Range Scans (NR)

      What is Narrow Range Scans (NR)

      Relative Strength (RS)

      Relative Strength (RS)

    • Fundamental Analysis
      • All
      • Cash Flow Ratios
      • Efficiency ratios
      • Growth Ratios
      • Liquidity Ratios
      • Return Ratios
      • Solvency ratios
      • Valuation Ratios
      Understanding the Importance of creating Fundamental Scans

      Understanding the Importance of creating Fundamental Scans

      Using My Combination Scan to Identify best in an Industry

      Using My Combination Scan to Identify best in an Industry

      Cost Income ratio

      Cost to Income Ratio(%)

      Cost of Liability

      Cost of Liabilities (%)

      Operating Cost to Assets Ratio (%)

      Operating Cost to Assets Ratio (%)

      Promoter pledge

      Promoter Pledge: Know Everything about it

    • StockEdge Tutorials
      StockEdge Version 8.1 – It keeps getting Better & Better

      StockEdge Version 8.1 – It keeps getting Better & Better

      StockEdge Version Update 8.0 – Like never before

      StockEdge Version Update 8.0 – Like never before

      Derivative Analytics

      Derivative Analytics – An Insightful Research Tool

      Market Breadth – A Bird’s Eye View of the Market at 1 place

      Market Breadth – A Bird’s Eye View of the Market at 1 place

      StockEdge Version 7.6 released – Enhancing your investment journey further!

      StockEdge Version 7.6 released – Enhancing your investment journey further!

      Using Investor Portfolios Section to track Big Bulls like Rakesh Jhunjhunwala

      Using Investor Portfolios Section to track Big Bulls like Rakesh Jhunjhunwala

      Beta & Beta Scans – A Powerful Technical Indicator

      Beta & Beta Scans – A Powerful Technical Indicator

      StockEdge Version Update 7.4 – Enhancing your Investment Journey

      StockEdge Version Update 7.4 – Enhancing your Investment Journey

      StockEdge 7.3 Release

      StockEdge 7.3 Release

    • Mutual Fund
      Top 5 Mutual Funds for 2022 where you can start your SIP

      Top 5 Mutual Funds for 2022 where you can start your SIP

      What are Value Funds and its Advantages?

      What are Value Funds and its Advantages?

      A Beginners Guide to Thematic Funds

      A Beginners Guide to Thematic Funds

      Understanding Sector Funds and their Benefits to our Portfolio

      Understanding Sector Funds and their Benefits to our Portfolio

      Are Dividend Yield Funds a good option to invest in?

      Are Dividend Yield Funds a good option to invest in?

      What are Contra Funds and their advantages?

      What are Contra Funds and their advantages?

      Trending Tags

      No Result
      View All Result
      StockEdge Blog
      Home Insights
      Biocon Limited – Transforming Healthcare. Transforming Lives.

      Biocon Limited – Transforming Healthcare. Transforming Lives.

      StockEdge by StockEdge
      March 3, 2021
      Reading Time: 5 mins read
      3.7k
      VIEWS
      Share on FacebookShare on TwitterShare On WhatsApp

      Table of Contents

      • The Story of Biocon Limited
      • Operational Highlights of Biocon Limited
      •  Future Outlook
      • Management Update
      • StockEdge Technical View
      • Bottom Line
      Biocon Limited

      The Story of Biocon Limited

      Established in 1978 with an initial seed capital of Rs 10,000 (US$ 140). Papain, an enzyme contained in papaya that is used to prevent beer from being hazy, was Biocon’s first product to go on the market. The company named Biocon Limited combined enzymes and supplied them to brewing, textiles, biofuels, animal feed, and other such industries around the world until 1983.

      Kiran Mazumdar Shaw started Biocon India in the garage of her rented house in Bangalore.

      It became the first company in India to be able to produce enzymes and export them to the United States and Europe within a year of its founding, overcoming all the major challenges.

      She listed Biocon Limited on the stock market in 2004, after seeking advice from Narayana Murthy, to raise capital to be able to further expand Biocon’s research programs. It was India’s first biotechnology company to go public.

      Today, Biocon Limited is an integrated innovation-led biopharmaceutical company engaged in discovering, developing and producing biologics in chronic therapies. Key products include statins, immunosuppressants anti-diabetic drugs and specialty enzymes.

      Biocon has shaped its business into 4 key growth verticals with the aim to deliver sustainable long term value for patients, partners and healthcare across the globe-biologics, branded formulations, small molecules and research services.

      Download StockEdge App Download StockEdge App Download StockEdge App
      Biocon Limited
      Biocon Limited

      Building on core expertise in APIs, the company forward integrated into Generic Formulations for both developed and emerging markets, a few years ago. To stay abreast of the ever-growing competition in the generics business, Biocon has chosen to focus on niche therapeutic areas such as oncology, diabetes, autoimmune diseases and immunosuppressants over the next few years. Initially, the product selection was focused on leveraging supply reliability due to vertical integration in the chronic space of cardiovascular drugs and other chosen therapeutic areas.

      Biocon Limited

      Operational Highlights of Biocon Limited

      • The revenues grew during Q3FY21 to Rs.1851 cr as compared to Rs.1717 cr in Q3FY20. For the Generics segment, the revenue stood at ₹561 crore in Q3 and declined by 6.3% QoQ
      • The EBITDA declined to Rs.399 cr in Q3FY21 as compared to Rs.444 cr in Q3FY20. The company had an expense of Rs.183 crore on account of research & development and employee costs during the quarter.
      Biocon Limited
      • The PAT declined at Rs.187 in Q3FY21 as compared to Rs.233 cr in Q3FY20.
      • Abu-Dhabi based, Abu Dhabi Developmental Holding Company (ADQ) would invest ₹555 crore for a minority stake of 1.8% in Biocon Biologics. The valuation of Biocon Biologics post investment would be $4.17 billion.
      Biocon Limited

       Future Outlook

      • The management is sticking to the earlier revenue target of USD 1 bn by FY22 for biologics business on back of the current portfolio as well as the forthcoming launches.
      • It received approval from the National Pharmaceutical Regulatory Agency (NPRA), Malaysia, for Insulin Aspart and Bevacizumab.
      • The Research Services increased by 12.5% QoQ to ₹585 crore during the quarter. Syngene entered into collaboration with 3DC (Deerfield Discovery and Development) and expanded Hyderabad facility by adding capacity for additional scientists.

      Management Update

      • The manufacturing capacity of Insulin in India & Malaysia has the dimension to support demand of developing as well as emerging market segments. Its entry into countries like Japan and Russia was impacted by Covid-related challenges, such as delays in good manufacturing practice (GMP) audits.
      • Goldman Sachs did a capital injection of $150 million in exchange for optionally convertible debentures of Biocon Biologics.
      • Over 100 patients, out of a total of 300, were enrolled in Phase 4 clinical studies for Itolizumab in treating CRS (cytokine release syndrome) in moderate to severe ARDS (acute respiratory distress syndrome) due to Covid.

      Read our latest article on Vinati Organics Limited – Shaping a Reliable Future

      StockEdge Technical View

      Biocon Limited

      Biocon has a strong support at 365-370 zone and likely to stay positive in the medium term till the stock holds above support zone. Weakness to get extended only below 360 level. Probable resistance in the medium term comes at 450 level. Technical parameters look neutral as of now.

      Bottom Line

      Biocon Limited continues to diversify its portfolio with launches of Pegfilgrastim and Trastuzumab in the US market with its partner Mylan. Company has also received the approval for Trastuzumab and Insulin Glargine and is all set to enter in Latin America and commonwealth independent states, and commenced supply of Insulin Glargine in Malaysia. Company also filed for three APIs in the key regulated market. Timely launches and ramp up of biosimilar in the developed as well as EMs and Syngene’s performances remain key levers for the company.

      New products launches and smooth operation ahead amidst US FDA approval for most of the facility should support longer-term earning growth prospectus. Also, the Branded formulation and Biologics segment (impacted by COVID-19) should recover gradually. Biocon Limited has a strong pipeline of biosimilars to be launched over the next 3-5 years across various markets. Despite the competition, the biosimilar products have good potential to gain market share from its peers based on its track record. The CEO of the Biologic division has stepped down.

      Click here to know more about the Premium offering of StockEdge.

      You can check out the desktop version of StockEdge using this link.

      Tags: BioconLtdInvestingstock insights
      ShareTweetSend
      Subscribe On Telegram Subscribe On Telegram Subscribe On Telegram
      Previous Post

      What are Value Funds and its Advantages?

      Next Post

      Indiabulls Group – Enabling Growth, Enabling Trust

      StockEdge

      StockEdge

      StockEdge is a self-help Equity and Mutual Fund research tool. It empowers retail investors to identify investment opportunity with all the necessary data and analytics.

      Related Posts

      How Page Industries is creating a “branded” opportunity in a fragmented market
      Insights

      How Page Industries is creating a “branded” opportunity in a fragmented market

      June 26, 2022
      4.1k
      5 Stocks which are Consistently Paying Dividend
      Insights

      5 Stocks which are Consistently Paying Dividend

      June 19, 2022
      30k
      Elgi Equipments – Enjoying Strong Tailwinds
      Insights

      Elgi Equipments – Enjoying Strong Tailwinds

      June 12, 2022
      5.8k
      Next Post
      Indiabulls Group – Enabling Growth, Enabling Trust

      Indiabulls Group – Enabling Growth, Enabling Trust

      Adaptive Relative Strength & Static Relative Strength Scans

      Adaptive Relative Strength & Static Relative Strength Scans

      StockEdge Version 6.0

      StockEdge Version 6.0

      Comments 4

      1. Ramesh Kousik says:
        1 year ago

        Very nice report …iam a begineer and got to know many thinghs from u guys .

        Thanks a lot

        Reply
        • StockEdge says:
          1 year ago

          We are glad you liked the content. Keep following us on Twitter to read more such Blogs!

          Reply
      2. Khalilur Choudhury says:
        1 year ago

        Hi Stock Edge team,

        You are doing a fabulous job. Your analysis and information sharing pattern are different, very easy to understand. Keep the good work continue. Lots of love.

        Reply
        • StockEdge says:
          1 year ago

          We are glad you liked the content. Keep following us on Twitter to read more such Blogs!

          Reply

      Leave a Reply Cancel reply

      Your email address will not be published. Required fields are marked *

      Contact Us

      • Timing (Mon-Sat): 10 am to 7 pm
      • Sales: +919830994463
      • Support: +919830994402
      • Club Support: +916289906895
      • Affiliate: +917003567131

      Recent Posts

      How Page Industries is creating a “branded” opportunity in a fragmented market

      June 26, 2022

      5 Stocks which are Consistently Paying Dividend

      June 19, 2022

      Important Links

      • StockEdge.com
      • StockEdge Premium
      • - Quarterly Membership
      • - Annual Membership
      • StockEdge Analyst
      • StockEdge Club
      • Compare Plans

      An Initiative Of

      © 2021 Kredent InfoEdge Pvt Ltd.

      Facebook-f Twitter Instagram Linkedin-in Youtube Pinterest-p

      Get StockEdge App

      No Result
      View All Result
      • Home
      • Article Categories
        • Fundamental Analysis
        • Technical Analysis
        • Market Themes
        • StockEdge Tutorials
        • StockEdge Version Updates
      • StockEdge Premium
        • Quarterly Membership
        • Annual Membership
        • StockEdge Analyst
        • StockEdge Club
        • Compare Plans
      • Visit StockEdge.com

      © 2021 Kredent InfoEdge Pvt Ltd.